MA40859A - Particules de cadotril - Google Patents
Particules de cadotrilInfo
- Publication number
- MA40859A MA40859A MA040859A MA40859A MA40859A MA 40859 A MA40859 A MA 40859A MA 040859 A MA040859 A MA 040859A MA 40859 A MA40859 A MA 40859A MA 40859 A MA40859 A MA 40859A
- Authority
- MA
- Morocco
- Prior art keywords
- cadotril
- particles
- cadotril particles
- Prior art date
Links
- ODUOJXZPIYUATO-UHFFFAOYSA-N 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester Chemical compound C=1C=CC=CC=1COC(=O)CNC(=O)C(CSC(=O)C)CC1=CC=CC=C1 ODUOJXZPIYUATO-UHFFFAOYSA-N 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 229960002281 racecadotril Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462069902P | 2014-10-29 | 2014-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA40859A true MA40859A (fr) | 2017-09-05 |
Family
ID=54478279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA040859A MA40859A (fr) | 2014-10-29 | 2015-10-28 | Particules de cadotril |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10022349B2 (fr) |
| EP (1) | EP3212179A1 (fr) |
| CN (1) | CN107072952A (fr) |
| BR (1) | BR112017008854A2 (fr) |
| CA (1) | CA2965685A1 (fr) |
| MA (1) | MA40859A (fr) |
| RU (1) | RU2017118329A (fr) |
| WO (1) | WO2016069871A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018013828A2 (pt) * | 2016-01-13 | 2018-12-11 | Johnson & Johnson Consumer Inc. | composição aprimorada que compreende ao menos uma cadotrila |
| US20190274964A1 (en) * | 2016-08-23 | 2019-09-12 | Johnson & Johnson Consumer Inc. | New improved composition of racecadotril |
| MX394171B (es) * | 2017-03-06 | 2025-03-24 | Athena Pharmaceutiques Sas | Una composicion farmaceutica que comprende racecadotrilo y procedimiento para preparar la misma |
| AU2018255510B2 (en) | 2017-04-20 | 2024-05-30 | Cubopharm Pty Ltd | Liquid crystalline dosage form for administering a statin |
| AU2018255509A1 (en) * | 2017-04-20 | 2019-12-05 | Zeenar Enterprises Pty Ltd | Process for preparing an oral disintegrating dosage form |
| US20210145737A1 (en) * | 2017-04-20 | 2021-05-20 | Zeenar Enterprises Pty Ltd | Fast disintegrating tablet |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485719A (en) | 1967-10-13 | 1969-12-23 | Us Agriculture | Continuous process for producing xanthomonas heteropolysaccharide |
| FR2480747A1 (fr) | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
| GB8317696D0 (en) | 1983-06-29 | 1983-08-03 | Shell Int Research | Preparing xanthomonas heteroplysaccharide |
| US4851226A (en) | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
| FR2623498B1 (fr) | 1987-11-24 | 1990-04-06 | Bioprojet Soc Civ | Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques |
| US5136076A (en) | 1987-11-24 | 1992-08-04 | Societe Civile Bioprojet | Process for the preparation of amino acid-derived enatiomeric compounds |
| US5075114A (en) | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
| CA2068402C (fr) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables |
| US5250236A (en) * | 1991-08-05 | 1993-10-05 | Gasco Maria R | Method for producing solid lipid microspheres having a narrow size distribution |
| EP0914822A4 (fr) | 1996-03-14 | 2002-08-07 | Bayer Ag | Preparation d'ecadotril a microdispersion et liberation rapides |
| GB0015490D0 (en) | 2000-06-23 | 2000-08-16 | Smithkline Beecham Lab | Novel formulations |
| DK1294372T3 (da) | 2000-06-23 | 2005-09-19 | Bioprojet Soc Civ | Törpulverformulering der omdanner racecadotril |
| EP1563848A1 (fr) | 2004-02-12 | 2005-08-17 | Bioprojet | Nouvelles combinaisons d' agents antiémétiques avec inhibiteurs de l'enképhalinase |
| FR2900823B1 (fr) | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| CN101103960B (zh) | 2006-07-14 | 2010-12-08 | 海南盛科生命科学研究院 | 一种含有消旋卡多曲的干混悬剂及其制备方法 |
| CN101264065A (zh) * | 2008-04-18 | 2008-09-17 | 盐城苏海制药有限公司 | 消旋卡多曲滴丸及其制备方法 |
| US8313768B2 (en) * | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
| ES2384060B1 (es) * | 2010-03-24 | 2013-09-23 | Lipotec S.A. | Cápsulas de nanopartículas lipídicas. |
| EP2462922A1 (fr) | 2010-12-10 | 2012-06-13 | Bioprojet | Nouvelle forme d'administration pour inhibiteurs de l'enképhalinase |
| CN102133186B (zh) | 2011-03-18 | 2012-08-01 | 海南美大制药有限公司 | 一种消旋卡多曲脂质体固体制剂 |
| CN102327234B (zh) | 2011-09-28 | 2017-04-12 | 海南康芝药业股份有限公司 | 一种消旋卡多曲干混悬剂 |
| JP6282644B2 (ja) | 2012-06-28 | 2018-02-21 | ジヨンソン・アンド・ジヨンソン・コンシユーマー・インコーポレーテツドJohnson & Johnson Consumer Inc. | ラセカドトリル液体組成物 |
| BR112014032759A2 (pt) | 2012-06-28 | 2017-06-27 | Mcneil Ppc Inc | composições lipídicas de racecadotril |
| US20140213653A1 (en) * | 2012-09-18 | 2014-07-31 | Mcneil-Ppc, Inc. | Directly compressible proprionic acid derivative particles |
| EP2749270B1 (fr) | 2012-12-26 | 2018-01-17 | ILKO Ilaç Sanayi ve Ticaret A.S. | Racécadotril et ses compositions pharmaceutiques |
-
2015
- 2015-10-28 MA MA040859A patent/MA40859A/fr unknown
- 2015-10-29 EP EP15791182.7A patent/EP3212179A1/fr not_active Withdrawn
- 2015-10-29 WO PCT/US2015/058007 patent/WO2016069871A1/fr not_active Ceased
- 2015-10-29 CN CN201580059479.9A patent/CN107072952A/zh not_active Withdrawn
- 2015-10-29 RU RU2017118329A patent/RU2017118329A/ru unknown
- 2015-10-29 BR BR112017008854A patent/BR112017008854A2/pt not_active Application Discontinuation
- 2015-10-29 US US14/926,533 patent/US10022349B2/en not_active Expired - Fee Related
- 2015-10-29 CA CA2965685A patent/CA2965685A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3212179A1 (fr) | 2017-09-06 |
| CA2965685A1 (fr) | 2016-05-06 |
| CN107072952A (zh) | 2017-08-18 |
| BR112017008854A2 (pt) | 2017-12-19 |
| WO2016069871A1 (fr) | 2016-05-06 |
| RU2017118329A (ru) | 2018-11-29 |
| US10022349B2 (en) | 2018-07-17 |
| US20160120834A1 (en) | 2016-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3183051T3 (da) | Væske-til-luftmembranenergivekslere | |
| DK3134402T3 (da) | 4-amino-imidazoquinolinforbindelser | |
| DK3006072T3 (da) | Karadgang | |
| DK3211743T3 (da) | Ø-til-netværk-omskiftningsfremgangsmåde | |
| DK3222714T3 (da) | Phytasemutanter | |
| DK3119396T3 (da) | Muscarinreceptoragonister | |
| DK3129122T3 (da) | Rensningssystem til lakpartikler | |
| EP3230438C0 (fr) | N-glycosylation | |
| DK3183340T3 (da) | Termolabile exonukleaser | |
| EP4011484C0 (fr) | Anhydrase carbonique de thermovibrio ammonificans | |
| DE112015001664A5 (de) | Betätigungsaktuator | |
| FR3018779B1 (fr) | Conditionnement | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| HUE057717T2 (hu) | Metotrexát készítmény | |
| DK3366357T3 (da) | Filter | |
| EP3359591A4 (fr) | Particules réticulées | |
| DE112015005041A5 (de) | Gargerätevorrichtung | |
| DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
| EP3395439A4 (fr) | Particules absorbantes | |
| DK3110439T3 (da) | Pcsk9-vacciner | |
| MA40859A (fr) | Particules de cadotril | |
| DE102014000623A8 (de) | Halbhohlnietelement | |
| EP3472297A4 (fr) | Particules esthétiques | |
| EP3288684A4 (fr) | Collecteur de particules électrocyclonique | |
| DK3009858T3 (da) | Skyradar |